Medartis Holding AG
SIX:MED
Medartis Holding AG
SIX:MED
Price:
76.5 CHF
-1.67%
Updated:
May 30, 2024
Medartis Holding AG
Cost of Revenue
|
Medartis Holding AG
Cost of Revenue Peer Comparison
Comparables:
ALC
CLTN
YPSN
VBSN
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Medartis Holding AG
SIX:MED
|
Cost of Revenue
-CHf44.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Alcon AG
SIX:ALC
|
Cost of Revenue
-$4.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Coltene Holding AG
SIX:CLTN
|
Cost of Revenue
-CHf95.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Ypsomed Holding AG
SIX:YPSN
|
Cost of Revenue
-CHf345.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
IVF Hartmann Holding AG
SIX:VBSN
|
Cost of Revenue
-CHf70m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
See Also
What is Medartis Holding AG's Cost of Revenue?
Cost of Revenue
-44.4m
CHF
-44.4m
CHF
Based on the financial report for Dec 31, 2023, Medartis Holding AG's Cost of Revenue amounts to -44.4m CHF.
What is Medartis Holding AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-17%
-17%
Over the last year, the Cost of Revenue growth was -33%. The average annual Cost of Revenue growth rates for Medartis Holding AG have been -28% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
